Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia

AIMS: Thrombocytopenia is often associated with chronic liver disease. Lusutrombopag is a small molecule thrombopoietin receptor agonist designed to temporarily increase the platelet count in patients with chronic liver disease for whom elective invasive procedures are planned. In the present study,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatol Res
Autors principals: Ishikawa, Toru, Okoshi, Marina, Tomiyoshi, Kei, Kojima, Yuichi, Horigome, Ryoko, Imai, Michitaka, Nozawa, Yujiro, Iwanaga, Akito, Sano, Tomoe, Honma, Terasu, Yoshida, Toshiaki
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849762/
https://ncbi.nlm.nih.gov/pubmed/30602063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hepr.13305
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars